

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | secondary metabolite biosynthetic process (GO:0044550) | 9.56122213 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.54785892 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 7.54785892 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 7.54785892 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 7.54785892 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.54785892 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.54785892 |
| 8 | cellular response to ATP (GO:0071318) | 6.36941050 |
| 9 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.23469333 |
| 10 | adenosine receptor signaling pathway (GO:0001973) | 6.07470730 |
| 11 | GDP-mannose metabolic process (GO:0019673) | 5.48162082 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.42999992 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 5.37305612 |
| 14 | pigment cell differentiation (GO:0050931) | 4.85843592 |
| 15 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.84981069 |
| 16 | adenine nucleotide transport (GO:0051503) | 4.81102227 |
| 17 | melanocyte differentiation (GO:0030318) | 4.77772985 |
| 18 | response to host immune response (GO:0052572) | 4.68995129 |
| 19 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.68995129 |
| 20 | purine ribonucleotide transport (GO:0015868) | 4.64223077 |
| 21 | positive regulation of protein kinase C signaling (GO:0090037) | 4.64059387 |
| 22 | glycosphingolipid catabolic process (GO:0046479) | 4.63300393 |
| 23 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.60380908 |
| 24 | positive regulation of interferon-alpha production (GO:0032727) | 4.59395365 |
| 25 | UV protection (GO:0009650) | 4.54968408 |
| 26 | neutrophil activation involved in immune response (GO:0002283) | 4.54113367 |
| 27 | regulation of cholesterol storage (GO:0010885) | 4.46956809 |
| 28 | low-density lipoprotein particle clearance (GO:0034383) | 4.30916459 |
| 29 | regulation of interferon-alpha production (GO:0032647) | 4.29139699 |
| 30 | positive regulation of antigen processing and presentation (GO:0002579) | 4.26502931 |
| 31 | immunoglobulin mediated immune response (GO:0016064) | 4.24664937 |
| 32 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.21306534 |
| 33 | response to host (GO:0075136) | 4.21306534 |
| 34 | response to host defenses (GO:0052200) | 4.21306534 |
| 35 | amino sugar catabolic process (GO:0046348) | 4.20541503 |
| 36 | oligosaccharide catabolic process (GO:0009313) | 4.19637369 |
| 37 | response to ATP (GO:0033198) | 4.13682154 |
| 38 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.11927202 |
| 39 | glycolipid catabolic process (GO:0019377) | 4.11852118 |
| 40 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.10396824 |
| 41 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.10396824 |
| 42 | mannose metabolic process (GO:0006013) | 3.92324530 |
| 43 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.92075355 |
| 44 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.88196333 |
| 45 | apoptotic cell clearance (GO:0043277) | 3.84509292 |
| 46 | microglial cell activation (GO:0001774) | 3.83975969 |
| 47 | lens fiber cell differentiation (GO:0070306) | 3.82121144 |
| 48 | purine nucleotide transport (GO:0015865) | 3.79407267 |
| 49 | negative regulation of cell aging (GO:0090344) | 3.77776109 |
| 50 | DNA strand renaturation (GO:0000733) | 3.77749617 |
| 51 | respiratory burst (GO:0045730) | 3.75494126 |
| 52 | nucleoside transmembrane transport (GO:1901642) | 3.74546150 |
| 53 | myeloid cell activation involved in immune response (GO:0002275) | 3.66725437 |
| 54 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.62866496 |
| 55 | pinocytosis (GO:0006907) | 3.61567071 |
| 56 | response to peptidoglycan (GO:0032494) | 3.60944296 |
| 57 | natural killer cell mediated immunity (GO:0002228) | 3.58393448 |
| 58 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.58393448 |
| 59 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.58137948 |
| 60 | ceramide catabolic process (GO:0046514) | 3.54903578 |
| 61 | macrophage activation (GO:0042116) | 3.54047426 |
| 62 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.52905628 |
| 63 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.52179634 |
| 64 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.52049984 |
| 65 | negative regulation of cell killing (GO:0031342) | 3.52049984 |
| 66 | lipoprotein transport (GO:0042953) | 3.50616259 |
| 67 | rRNA methylation (GO:0031167) | 3.46383342 |
| 68 | purinergic receptor signaling pathway (GO:0035587) | 3.45990252 |
| 69 | tyrosine metabolic process (GO:0006570) | 3.37189879 |
| 70 | positive regulation of B cell differentiation (GO:0045579) | 3.35562017 |
| 71 | meiotic chromosome segregation (GO:0045132) | 3.35521223 |
| 72 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.35355105 |
| 73 | regulation of antigen processing and presentation (GO:0002577) | 3.34443668 |
| 74 | sphingolipid catabolic process (GO:0030149) | 3.33030607 |
| 75 | basement membrane organization (GO:0071711) | 3.31822521 |
| 76 | phenol-containing compound biosynthetic process (GO:0046189) | 3.30713743 |
| 77 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.29906273 |
| 78 | neutrophil mediated immunity (GO:0002446) | 3.29448293 |
| 79 | membrane lipid catabolic process (GO:0046466) | 3.26419572 |
| 80 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.21597958 |
| 81 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.18691948 |
| 82 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.16409334 |
| 83 | positive regulation of interferon-beta production (GO:0032728) | 3.14673099 |
| 84 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.14549994 |
| 85 | phagosome maturation (GO:0090382) | 3.14442269 |
| 86 | histone phosphorylation (GO:0016572) | 3.12894459 |
| 87 | granulocyte activation (GO:0036230) | 3.10390066 |
| 88 | positive regulation of odontogenesis (GO:0042482) | 3.08699719 |
| 89 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.07820108 |
| 90 | positive regulation of T cell apoptotic process (GO:0070234) | 3.07776933 |
| 91 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.07195305 |
| 92 | barbed-end actin filament capping (GO:0051016) | 3.06957093 |
| 93 | sphingosine metabolic process (GO:0006670) | 3.06465822 |
| 94 | sensory perception of taste (GO:0050909) | 3.04387277 |
| 95 | positive regulation of mast cell activation (GO:0033005) | 3.03196232 |
| 96 | B cell mediated immunity (GO:0019724) | 2.98477647 |
| 97 | N-acetylneuraminate metabolic process (GO:0006054) | 2.98333905 |
| 98 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.97795781 |
| 99 | response to thyroid hormone (GO:0097066) | 2.97360434 |
| 100 | positive regulation of bone remodeling (GO:0046852) | 2.95876882 |
| 101 | positive regulation of bone resorption (GO:0045780) | 2.95876882 |
| 102 | regulation of mast cell degranulation (GO:0043304) | 2.92994791 |
| 103 | neutrophil activation (GO:0042119) | 2.92802130 |
| 104 | regulation of early endosome to late endosome transport (GO:2000641) | 2.92233689 |
| 105 | response to lipoprotein particle (GO:0055094) | 2.90906824 |
| 106 | regulation of leukocyte degranulation (GO:0043300) | 2.90031295 |
| 107 | defense response to protozoan (GO:0042832) | 2.89949396 |
| 108 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.89764555 |
| 109 | pigment biosynthetic process (GO:0046148) | 2.89005579 |
| 110 | response to muramyl dipeptide (GO:0032495) | 2.88795217 |
| 111 | I-kappaB phosphorylation (GO:0007252) | 2.87709362 |
| 112 | decidualization (GO:0046697) | 2.87103550 |
| 113 | regulation of protein kinase A signaling (GO:0010738) | 2.87003637 |
| 114 | regulation of integrin activation (GO:0033623) | 2.85536166 |
| 115 | negative regulation of phagocytosis (GO:0050765) | 2.85066508 |
| 116 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.84698190 |
| 117 | nucleoside transport (GO:0015858) | 2.84187982 |
| 118 | positive regulation of macrophage cytokine production (GO:0060907) | 2.84070351 |
| 119 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.83212808 |
| 120 | negative regulation of interleukin-17 production (GO:0032700) | 2.82792905 |
| 121 | negative regulation of interleukin-6 production (GO:0032715) | 2.82465973 |
| 122 | adhesion of symbiont to host (GO:0044406) | 2.82257376 |
| 123 | negative regulation of granulocyte differentiation (GO:0030853) | 2.81996411 |
| 124 | basic amino acid transport (GO:0015802) | 2.81844151 |
| 125 | protein carboxylation (GO:0018214) | 2.80924052 |
| 126 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.80924052 |
| 127 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.80297195 |
| 128 | endosome to melanosome transport (GO:0035646) | 2.80256520 |
| 129 | endosome to pigment granule transport (GO:0043485) | 2.80256520 |
| 130 | hyaluronan catabolic process (GO:0030214) | 2.80190948 |
| 131 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.79140660 |
| 132 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.78715934 |
| 133 | regulation of mast cell activation (GO:0033003) | 2.76095098 |
| 134 | regulation of phagocytosis (GO:0050764) | 2.75691871 |
| 135 | ganglioside metabolic process (GO:0001573) | 2.75581976 |
| 136 | regulation of protein sumoylation (GO:0033233) | 2.73971850 |
| 137 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.73251094 |
| 138 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.72613095 |
| 139 | regulation of skeletal muscle contraction (GO:0014819) | 2.72156554 |
| 140 | regulation of mononuclear cell migration (GO:0071675) | 2.70753829 |
| 141 | intracellular pH reduction (GO:0051452) | 2.70013521 |
| 142 | positive regulation of heat generation (GO:0031652) | 2.69861433 |
| 143 | rRNA modification (GO:0000154) | 2.69595427 |
| 144 | osteoclast differentiation (GO:0030316) | 2.69275349 |
| 145 | regulation of macrophage cytokine production (GO:0010935) | 2.68014161 |
| 146 | modulation by symbiont of host cellular process (GO:0044068) | 2.67474555 |
| 147 | sialylation (GO:0097503) | 2.67208865 |
| 148 | positive regulation of leukocyte degranulation (GO:0043302) | 2.67103061 |
| 149 | diol metabolic process (GO:0034311) | 2.65797906 |
| 150 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.65714816 |
| 151 | positive regulation of phagocytosis (GO:0050766) | 2.65640209 |
| 152 | interaction with host (GO:0051701) | 2.65315549 |
| 153 | pentose-phosphate shunt (GO:0006098) | 2.65252355 |
| 154 | nucleotide transmembrane transport (GO:1901679) | 2.64993571 |
| 155 | regulation of vitamin metabolic process (GO:0030656) | 2.64889221 |
| 156 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.64250551 |
| 157 | neuroepithelial cell differentiation (GO:0060563) | 2.61901302 |
| 158 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.61339354 |
| 159 | lymphocyte mediated immunity (GO:0002449) | 2.59659655 |
| 160 | leukocyte mediated cytotoxicity (GO:0001909) | 2.58415952 |
| 161 | semaphorin-plexin signaling pathway (GO:0071526) | 2.58251259 |
| 162 | negative regulation of mast cell activation (GO:0033004) | 2.58210431 |
| 163 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.57974614 |
| 164 | negative regulation of lipid storage (GO:0010888) | 2.57741425 |
| 165 | secondary metabolic process (GO:0019748) | 2.55200502 |
| 166 | cytokine production involved in immune response (GO:0002367) | 2.54674146 |
| 167 | response to interferon-alpha (GO:0035455) | 2.54010751 |
| 168 | negative regulation of interleukin-12 production (GO:0032695) | 2.53225694 |
| 169 | protein localization to endosome (GO:0036010) | 2.52284306 |
| 170 | keratan sulfate catabolic process (GO:0042340) | 2.52210578 |
| 171 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.51087775 |
| 172 | keratan sulfate metabolic process (GO:0042339) | 2.49953928 |
| 173 | modulation by virus of host process (GO:0019054) | 2.48978864 |
| 174 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.45523544 |
| 175 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.44096792 |
| 176 | endocytic recycling (GO:0032456) | 2.43364488 |
| 177 | regulation of monocyte differentiation (GO:0045655) | 2.41937033 |
| 178 | adhesion of symbiont to host cell (GO:0044650) | 2.36549267 |
| 179 | virion attachment to host cell (GO:0019062) | 2.36549267 |
| 180 | negative regulation of macroautophagy (GO:0016242) | 2.35496445 |
| 181 | regulated secretory pathway (GO:0045055) | 2.35064365 |
| 182 | protein retention in ER lumen (GO:0006621) | 2.34281529 |
| 183 | melanin biosynthetic process (GO:0042438) | 11.9317400 |
| 184 | melanin metabolic process (GO:0006582) | 10.9056953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.07531172 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.45813524 |
| 3 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.68323408 |
| 4 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.67542208 |
| 5 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.33932142 |
| 6 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.32385097 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.28602409 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.95938607 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.93421536 |
| 10 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.88064326 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.79677409 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.75160726 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.72473601 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.65372366 |
| 15 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.56443225 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.28931882 |
| 17 | P68_20966046_ChIP-Seq_HELA_Human | 2.28107751 |
| 18 | SPI1_23127762_ChIP-Seq_K562_Human | 2.24351664 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.18630678 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 2.15479269 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.15099150 |
| 22 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.14878172 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.06243911 |
| 24 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.02899722 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.99976717 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.99640022 |
| 27 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.96417892 |
| 28 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.94629224 |
| 29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.94470700 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94425556 |
| 31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.93962989 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.91497612 |
| 33 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.83880007 |
| 34 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.83076000 |
| 35 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.82769947 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.82222715 |
| 37 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.80049740 |
| 38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.79659795 |
| 39 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.77788677 |
| 40 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.75886405 |
| 41 | MAF_26560356_Chip-Seq_TH1_Human | 1.73903756 |
| 42 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.72560120 |
| 43 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.66553859 |
| 44 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.66199650 |
| 45 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.64334465 |
| 46 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.63034888 |
| 47 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.62182933 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.61198530 |
| 49 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.59060284 |
| 50 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.58888244 |
| 51 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.58144806 |
| 52 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.56933792 |
| 53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.53975070 |
| 54 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.52664958 |
| 55 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51929930 |
| 56 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51832574 |
| 57 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.51819033 |
| 58 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.51489026 |
| 59 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.51080606 |
| 60 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.49491106 |
| 61 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.48405937 |
| 62 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.48031482 |
| 63 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.46054969 |
| 64 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.45525269 |
| 65 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.45188512 |
| 66 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.43437466 |
| 67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.43247890 |
| 68 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.42024912 |
| 69 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.41413907 |
| 70 | UTX_26944678_Chip-Seq_JUKART_Human | 1.40932632 |
| 71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.40778511 |
| 72 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.40313361 |
| 73 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.39659623 |
| 74 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.38941820 |
| 75 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38869382 |
| 76 | GATA1_19941826_ChIP-Seq_K562_Human | 1.37985472 |
| 77 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37899896 |
| 78 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.36978272 |
| 79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.36821935 |
| 80 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.36460939 |
| 81 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.34413505 |
| 82 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.34254389 |
| 83 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33559999 |
| 84 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.33356450 |
| 85 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.32033991 |
| 86 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.30087973 |
| 87 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.29999894 |
| 88 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.29703407 |
| 89 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29500529 |
| 90 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.29395000 |
| 91 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.26791881 |
| 92 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24722973 |
| 93 | MYB_26560356_Chip-Seq_TH2_Human | 1.24365767 |
| 94 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.24176630 |
| 95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23514164 |
| 96 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23263938 |
| 97 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.22619683 |
| 98 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.22450580 |
| 99 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.22347404 |
| 100 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.21783074 |
| 101 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.19792579 |
| 102 | MYB_26560356_Chip-Seq_TH1_Human | 1.19575977 |
| 103 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19390943 |
| 104 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.19367932 |
| 105 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.18741292 |
| 106 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.18019463 |
| 107 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.17236011 |
| 108 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.15549705 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15460981 |
| 110 | MAF_26560356_Chip-Seq_TH2_Human | 1.15397886 |
| 111 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14707931 |
| 112 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13635307 |
| 113 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.13595556 |
| 114 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.13481774 |
| 115 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12701905 |
| 116 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12369955 |
| 117 | SA1_27219007_Chip-Seq_Bcells_Human | 1.12189631 |
| 118 | MITF_21258399_ChIP-Seq_MELANOMA_Human | 1.11870646 |
| 119 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.11006922 |
| 120 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10865269 |
| 121 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.10437520 |
| 122 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10314969 |
| 123 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09815909 |
| 124 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09132553 |
| 125 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07903781 |
| 126 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.07173519 |
| 127 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.06862349 |
| 128 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05842777 |
| 129 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05552336 |
| 130 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.05291288 |
| 131 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03119141 |
| 132 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02662172 |
| 133 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01661617 |
| 134 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01192011 |
| 135 | KDM2B_26808549_Chip-Seq_K562_Human | 1.00815776 |
| 136 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.00225307 |
| 137 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98509664 |
| 138 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96940390 |
| 139 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.94305608 |
| 140 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.94272741 |
| 141 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93644225 |
| 142 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93119453 |
| 143 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92959845 |
| 144 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91691242 |
| 145 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.91676092 |
| 146 | ATF3_27146783_Chip-Seq_COLON_Human | 0.90480271 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005171_absent_coat_pigmentation | 7.96800986 |
| 2 | MP0003136_yellow_coat_color | 7.35088257 |
| 3 | MP0005058_abnormal_lysosome_morphology | 5.67987046 |
| 4 | MP0003172_abnormal_lysosome_physiology | 4.61843641 |
| 5 | MP0005409_darkened_coat_color | 4.30603166 |
| 6 | MP0004381_abnormal_hair_follicle | 3.73932744 |
| 7 | MP0002877_abnormal_melanocyte_morpholog | 3.66139938 |
| 8 | MP0003303_peritoneal_inflammation | 3.65270162 |
| 9 | MP0000569_abnormal_digit_pigmentation | 3.64861110 |
| 10 | MP0009840_abnormal_foam_cell | 3.43549673 |
| 11 | MP0001188_hyperpigmentation | 2.97498893 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.90150471 |
| 13 | MP0006082_CNS_inflammation | 2.90036211 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.88384530 |
| 15 | MP0004510_myositis | 2.78181335 |
| 16 | MP0000372_irregular_coat_pigmentation | 2.76714110 |
| 17 | MP0003436_decreased_susceptibility_to | 2.76213211 |
| 18 | MP0001986_abnormal_taste_sensitivity | 2.76190209 |
| 19 | MP0005257_abnormal_intraocular_pressure | 2.75893343 |
| 20 | MP0005423_abnormal_somatic_nervous | 2.72172765 |
| 21 | MP0002419_abnormal_innate_immunity | 2.53413617 |
| 22 | MP0000604_amyloidosis | 2.34388509 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.15486863 |
| 24 | MP0010307_abnormal_tumor_latency | 2.13585392 |
| 25 | MP0005174_abnormal_tail_pigmentation | 2.11624104 |
| 26 | MP0003300_gastrointestinal_ulcer | 2.00292696 |
| 27 | MP0005075_abnormal_melanosome_morpholog | 1.99792190 |
| 28 | MP0003690_abnormal_glial_cell | 1.97650118 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 1.96254530 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.96190379 |
| 31 | MP0002452_abnormal_antigen_presenting | 1.94784392 |
| 32 | MP0002075_abnormal_coat/hair_pigmentati | 1.94767182 |
| 33 | MP0002095_abnormal_skin_pigmentation | 1.93123326 |
| 34 | MP0005025_abnormal_response_to | 1.91185906 |
| 35 | MP0005408_hypopigmentation | 1.90128799 |
| 36 | MP0003453_abnormal_keratinocyte_physiol | 1.84760140 |
| 37 | MP0009278_abnormal_bone_marrow | 1.81579688 |
| 38 | MP0003656_abnormal_erythrocyte_physiolo | 1.79468104 |
| 39 | MP0001790_abnormal_immune_system | 1.77592631 |
| 40 | MP0005387_immune_system_phenotype | 1.77592631 |
| 41 | MP0005451_abnormal_body_composition | 1.70554532 |
| 42 | MP0003566_abnormal_cell_adhesion | 1.66004893 |
| 43 | MP0004858_abnormal_nervous_system | 1.64086208 |
| 44 | MP0003448_altered_tumor_morphology | 1.63981848 |
| 45 | MP0002723_abnormal_immune_serum | 1.63620019 |
| 46 | MP0000685_abnormal_immune_system | 1.62918559 |
| 47 | MP0001800_abnormal_humoral_immune | 1.62861991 |
| 48 | MP0003075_altered_response_to | 1.57002593 |
| 49 | MP0004130_abnormal_muscle_cell | 1.56975928 |
| 50 | MP0001819_abnormal_immune_cell | 1.56153254 |
| 51 | MP0004947_skin_inflammation | 1.55607961 |
| 52 | MP0002420_abnormal_adaptive_immunity | 1.55046374 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.53330470 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.53330470 |
| 55 | MP0001186_pigmentation_phenotype | 1.51046219 |
| 56 | MP0003183_abnormal_peptide_metabolism | 1.47626542 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.47181880 |
| 58 | MP0009785_altered_susceptibility_to | 1.45695138 |
| 59 | MP0002405_respiratory_system_inflammati | 1.44115203 |
| 60 | MP0002148_abnormal_hypersensitivity_rea | 1.40353119 |
| 61 | MP0005083_abnormal_biliary_tract | 1.37070231 |
| 62 | MP0005310_abnormal_salivary_gland | 1.36017898 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.32230789 |
| 64 | MP0000689_abnormal_spleen_morphology | 1.30516749 |
| 65 | MP0000465_gastrointestinal_hemorrhage | 1.30335079 |
| 66 | MP0004185_abnormal_adipocyte_glucose | 1.24894533 |
| 67 | MP0005076_abnormal_cell_differentiation | 1.24713425 |
| 68 | MP0008469_abnormal_protein_level | 1.23763795 |
| 69 | MP0001845_abnormal_inflammatory_respons | 1.23161314 |
| 70 | MP0000015_abnormal_ear_pigmentation | 1.21293541 |
| 71 | MP0000716_abnormal_immune_system | 1.19111840 |
| 72 | MP0005167_abnormal_blood-brain_barrier | 1.18970334 |
| 73 | MP0000343_altered_response_to | 1.17162777 |
| 74 | MP0002398_abnormal_bone_marrow | 1.16551927 |
| 75 | MP0000858_altered_metastatic_potential | 1.12582888 |
| 76 | MP0002090_abnormal_vision | 1.12273495 |
| 77 | MP0001958_emphysema | 1.11401279 |
| 78 | MP0002722_abnormal_immune_system | 1.09102854 |
| 79 | MP0008438_abnormal_cutaneous_collagen | 1.06641129 |
| 80 | MP0002429_abnormal_blood_cell | 1.06008120 |
| 81 | MP0001324_abnormal_eye_pigmentation | 1.04472157 |
| 82 | MP0005166_decreased_susceptibility_to | 1.00527110 |
| 83 | MP0001851_eye_inflammation | 1.00434251 |
| 84 | MP0009333_abnormal_splenocyte_physiolog | 1.00367164 |
| 85 | MP0005671_abnormal_response_to | 1.00328348 |
| 86 | MP0000371_diluted_coat_color | 0.99567734 |
| 87 | MP0002166_altered_tumor_susceptibility | 0.98579650 |
| 88 | MP0005670_abnormal_white_adipose | 0.98467258 |
| 89 | MP0003806_abnormal_nucleotide_metabolis | 0.97379683 |
| 90 | MP0003634_abnormal_glial_cell | 0.89493283 |
| 91 | MP0010329_abnormal_lipoprotein_level | 0.88925438 |
| 92 | MP0002254_reproductive_system_inflammat | 0.88689789 |
| 93 | MP0001756_abnormal_urination | 0.87814603 |
| 94 | MP0003724_increased_susceptibility_to | 0.87809846 |
| 95 | MP0003878_abnormal_ear_physiology | 0.85467017 |
| 96 | MP0005377_hearing/vestibular/ear_phenot | 0.85467017 |
| 97 | MP0003329_amyloid_beta_deposits | 0.83397552 |
| 98 | MP0009115_abnormal_fat_cell | 0.79324520 |
| 99 | MP0003091_abnormal_cell_migration | 0.78300331 |
| 100 | MP0001849_ear_inflammation | 0.78116790 |
| 101 | MP0004808_abnormal_hematopoietic_stem | 0.77279166 |
| 102 | MP0001853_heart_inflammation | 0.76115230 |
| 103 | MP0010155_abnormal_intestine_physiology | 0.75412293 |
| 104 | MP0000609_abnormal_liver_physiology | 0.74941751 |
| 105 | MP0003111_abnormal_nucleus_morphology | 0.74731254 |
| 106 | MP0008260_abnormal_autophagy | 0.73198149 |
| 107 | MP0001968_abnormal_touch/_nociception | 0.73126462 |
| 108 | MP0002396_abnormal_hematopoietic_system | 0.72863445 |
| 109 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.72472474 |
| 110 | MP0002089_abnormal_postnatal_growth/wei | 0.70516898 |
| 111 | MP0000367_abnormal_coat/_hair | 0.70231267 |
| 112 | MP0005666_abnormal_adipose_tissue | 0.68836166 |
| 113 | MP0003011_delayed_dark_adaptation | 0.68623073 |
| 114 | MP0000598_abnormal_liver_morphology | 0.68551233 |
| 115 | MP0009764_decreased_sensitivity_to | 0.67215122 |
| 116 | MP0001348_abnormal_lacrimal_gland | 0.65993255 |
| 117 | MP0002638_abnormal_pupillary_reflex | 0.64125943 |
| 118 | MP0004019_abnormal_vitamin_homeostasis | 0.63681310 |
| 119 | MP0009763_increased_sensitivity_to | 0.63681154 |
| 120 | MP0000003_abnormal_adipose_tissue | 0.63453112 |
| 121 | MP0005365_abnormal_bile_salt | 0.63453059 |
| 122 | MP0000490_abnormal_crypts_of | 0.63354907 |
| 123 | MP0000920_abnormal_myelination | 0.63122499 |
| 124 | MP0000751_myopathy | 0.62058798 |
| 125 | MP0001873_stomach_inflammation | 0.61783230 |
| 126 | MP0001915_intracranial_hemorrhage | 0.61770026 |
| 127 | MP0002006_tumorigenesis | 0.61654772 |
| 128 | MP0010386_abnormal_urinary_bladder | 0.60354734 |
| 129 | MP0005197_abnormal_uvea_morphology | 0.59250683 |
| 130 | MP0003828_pulmonary_edema | 0.58638001 |
| 131 | MP0002933_joint_inflammation | 0.58613897 |
| 132 | MP0008961_abnormal_basal_metabolism | 0.58075938 |
| 133 | MP0003279_aneurysm | 0.56276427 |
| 134 | MP0000750_abnormal_muscle_regeneration | 0.54670203 |
| 135 | MP0000747_muscle_weakness | 0.54221331 |
| 136 | MP0000358_abnormal_cell_content/ | 0.54076169 |
| 137 | MP0001502_abnormal_circadian_rhythm | 0.53913111 |
| 138 | MP0002139_abnormal_hepatobiliary_system | 0.53234930 |
| 139 | MP0004233_abnormal_muscle_weight | 0.53210910 |
| 140 | MP0010234_abnormal_vibrissa_follicle | 0.50911821 |
| 141 | MP0004043_abnormal_pH_regulation | 0.42113528 |
| 142 | MP0000538_abnormal_urinary_bladder | 0.41761624 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased cerebral lipofuscin (HP:0011813) | 7.70103493 |
| 2 | Vacuolated lymphocytes (HP:0001922) | 5.87456124 |
| 3 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.86383945 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.40892160 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.40892160 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 5.40892160 |
| 7 | Recurrent abscess formation (HP:0002722) | 5.27443740 |
| 8 | Ocular albinism (HP:0001107) | 5.25435502 |
| 9 | Dysostosis multiplex (HP:0000943) | 4.92178384 |
| 10 | Thin bony cortex (HP:0002753) | 4.90004462 |
| 11 | White forelock (HP:0002211) | 4.79971172 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 4.49207982 |
| 13 | Loss of speech (HP:0002371) | 4.46316318 |
| 14 | Ulnar bowing (HP:0003031) | 4.34526153 |
| 15 | Eczematoid dermatitis (HP:0000976) | 4.34180464 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.30754663 |
| 17 | Iris hypopigmentation (HP:0007730) | 4.30333354 |
| 18 | Abnormality of macrophages (HP:0004311) | 4.27156058 |
| 19 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.22479814 |
| 20 | Mucopolysacchariduria (HP:0008155) | 4.22479814 |
| 21 | Annular pancreas (HP:0001734) | 4.20122525 |
| 22 | Axonal loss (HP:0003447) | 4.19471006 |
| 23 | Patchy hypopigmentation of hair (HP:0011365) | 4.10495023 |
| 24 | Disinhibition (HP:0000734) | 4.09460925 |
| 25 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.08361245 |
| 26 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.08361245 |
| 27 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.08361245 |
| 28 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.69883289 |
| 29 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.63819692 |
| 30 | Global brain atrophy (HP:0002283) | 3.61459149 |
| 31 | Turricephaly (HP:0000262) | 3.59644429 |
| 32 | Premature graying of hair (HP:0002216) | 3.48904031 |
| 33 | Testicular atrophy (HP:0000029) | 3.46748052 |
| 34 | Rib fusion (HP:0000902) | 3.42710988 |
| 35 | Hypoplasia of the fovea (HP:0007750) | 3.36963127 |
| 36 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.36963127 |
| 37 | Systemic lupus erythematosus (HP:0002725) | 3.31028014 |
| 38 | Upper motor neuron abnormality (HP:0002127) | 3.27085642 |
| 39 | Poikiloderma (HP:0001029) | 3.20754950 |
| 40 | Vaginal fistula (HP:0004320) | 3.15261269 |
| 41 | Neuronal loss in central nervous system (HP:0002529) | 3.13042728 |
| 42 | J-shaped sella turcica (HP:0002680) | 3.12052085 |
| 43 | Autoimmune thrombocytopenia (HP:0001973) | 3.08546271 |
| 44 | Rectovaginal fistula (HP:0000143) | 3.03755079 |
| 45 | Rectal fistula (HP:0100590) | 3.03755079 |
| 46 | Intestinal fistula (HP:0100819) | 3.02865205 |
| 47 | Myocardial infarction (HP:0001658) | 3.00688051 |
| 48 | Supranuclear gaze palsy (HP:0000605) | 3.00408697 |
| 49 | Gingivitis (HP:0000230) | 3.00013832 |
| 50 | Agnosia (HP:0010524) | 2.91719260 |
| 51 | Asymmetric septal hypertrophy (HP:0001670) | 2.90519268 |
| 52 | Joint stiffness (HP:0001387) | 2.90504542 |
| 53 | Akinesia (HP:0002304) | 2.86742371 |
| 54 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.84792477 |
| 55 | Nuclear cataract (HP:0100018) | 2.81259284 |
| 56 | Delayed epiphyseal ossification (HP:0002663) | 2.76964213 |
| 57 | Blue irides (HP:0000635) | 2.74362166 |
| 58 | Facial hemangioma (HP:0000329) | 2.70416431 |
| 59 | Diminished motivation (HP:0000745) | 2.69755245 |
| 60 | Apathy (HP:0000741) | 2.69247145 |
| 61 | Recurrent skin infections (HP:0001581) | 2.68736543 |
| 62 | Hepatosplenomegaly (HP:0001433) | 2.66951608 |
| 63 | Vertebral compression fractures (HP:0002953) | 2.63227736 |
| 64 | Abnormality of the costochondral junction (HP:0000919) | 2.63206061 |
| 65 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.61899060 |
| 66 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.59845745 |
| 67 | Thoracic kyphosis (HP:0002942) | 2.59486821 |
| 68 | Male infertility (HP:0003251) | 2.58243250 |
| 69 | Neoplasm of head and neck (HP:0012288) | 2.57800109 |
| 70 | Esophageal neoplasm (HP:0100751) | 2.57800109 |
| 71 | Increased CSF protein (HP:0002922) | 2.56017729 |
| 72 | Abnormality of the fovea (HP:0000493) | 2.55236206 |
| 73 | Peripheral demyelination (HP:0011096) | 2.55086315 |
| 74 | Mediastinal lymphadenopathy (HP:0100721) | 2.53239280 |
| 75 | Chronic obstructive pulmonary disease (HP:0006510) | 2.51604667 |
| 76 | Obstructive lung disease (HP:0006536) | 2.51604667 |
| 77 | Personality changes (HP:0000751) | 2.50533740 |
| 78 | Pathologic fracture (HP:0002756) | 2.48531433 |
| 79 | Flat occiput (HP:0005469) | 2.44806544 |
| 80 | Chronic otitis media (HP:0000389) | 2.43375931 |
| 81 | Conjunctival telangiectasia (HP:0000524) | 2.43101782 |
| 82 | Mutism (HP:0002300) | 2.42927193 |
| 83 | Recurrent fungal infections (HP:0002841) | 2.42476367 |
| 84 | Cellulitis (HP:0100658) | 2.42268827 |
| 85 | Nasal polyposis (HP:0100582) | 2.40793130 |
| 86 | Hypopigmentation of the fundus (HP:0007894) | 2.36469779 |
| 87 | Retinal atrophy (HP:0001105) | 2.36340935 |
| 88 | Myositis (HP:0100614) | 2.35244307 |
| 89 | Interstitial pulmonary disease (HP:0006530) | 2.35101713 |
| 90 | Inappropriate behavior (HP:0000719) | 2.34750184 |
| 91 | Enlarged epiphyses (HP:0010580) | 2.34357578 |
| 92 | Anteriorly placed anus (HP:0001545) | 2.33727706 |
| 93 | Squamous cell carcinoma (HP:0002860) | 2.33560164 |
| 94 | Glomerulonephritis (HP:0000099) | 2.30926079 |
| 95 | Periodontitis (HP:0000704) | 2.29387806 |
| 96 | Abnormality of the nasal mucosa (HP:0000433) | 2.27544516 |
| 97 | Popliteal pterygium (HP:0009756) | 2.25540526 |
| 98 | Coronal craniosynostosis (HP:0004440) | 2.25179502 |
| 99 | Deformed sella turcica (HP:0002681) | 2.24743773 |
| 100 | Hemorrhage of the eye (HP:0011885) | 2.20787732 |
| 101 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.20303204 |
| 102 | Short chin (HP:0000331) | 2.19771195 |
| 103 | Freckling (HP:0001480) | 2.18669008 |
| 104 | Hypercholesterolemia (HP:0003124) | 2.18348551 |
| 105 | Abnormality of the intrinsic pathway (HP:0010989) | 2.18249112 |
| 106 | Abnormality of the thoracic spine (HP:0100711) | 2.17887690 |
| 107 | Metaphyseal irregularity (HP:0003025) | 2.17536889 |
| 108 | Bowing of the arm (HP:0006488) | 2.15713310 |
| 109 | Bowed forearm bones (HP:0003956) | 2.15713310 |
| 110 | Zonular cataract (HP:0010920) | 2.15598465 |
| 111 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.14417933 |
| 112 | Hematochezia (HP:0002573) | 2.12706592 |
| 113 | Cerebral aneurysm (HP:0004944) | 2.12498426 |
| 114 | Neurodegeneration (HP:0002180) | 2.11398320 |
| 115 | Impaired platelet aggregation (HP:0003540) | 2.11110908 |
| 116 | Abnormal platelet function (HP:0011869) | 2.11110908 |
| 117 | Abnormality of the lumbar spine (HP:0100712) | 2.10901077 |
| 118 | Abnormality of the periventricular white matter (HP:0002518) | 2.10455074 |
| 119 | Dyschromatopsia (HP:0007641) | 2.10125188 |
| 120 | Pustule (HP:0200039) | 2.09586373 |
| 121 | Congenital stationary night blindness (HP:0007642) | 2.06655795 |
| 122 | Osteomyelitis (HP:0002754) | 2.06628473 |
| 123 | Hand muscle atrophy (HP:0009130) | 2.05641199 |
| 124 | Colitis (HP:0002583) | 2.01552650 |
| 125 | Frequent falls (HP:0002359) | 2.01451008 |
| 126 | Albinism (HP:0001022) | 2.01404140 |
| 127 | Spastic tetraparesis (HP:0001285) | 1.97031359 |
| 128 | Orchitis (HP:0100796) | 1.96318462 |
| 129 | Bone pain (HP:0002653) | 1.95852407 |
| 130 | Neurofibrillary tangles (HP:0002185) | 1.95349804 |
| 131 | Urticaria (HP:0001025) | 1.95268346 |
| 132 | Recurrent viral infections (HP:0004429) | 1.94621118 |
| 133 | Poor head control (HP:0002421) | 1.93971651 |
| 134 | Basal ganglia calcification (HP:0002135) | 1.92559216 |
| 135 | Heterochromia iridis (HP:0001100) | 1.91774089 |
| 136 | Upper limb amyotrophy (HP:0009129) | 1.91481784 |
| 137 | Distal upper limb amyotrophy (HP:0007149) | 1.91481784 |
| 138 | Reticulocytosis (HP:0001923) | 1.91368713 |
| 139 | Cerebral inclusion bodies (HP:0100314) | 1.90419048 |
| 140 | Aplasia of the musculature (HP:0100854) | 1.89420974 |
| 141 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.89130281 |
| 142 | Osteolytic defects of the hand bones (HP:0009699) | 1.89130281 |
| 143 | Protuberant abdomen (HP:0001538) | 1.88727069 |
| 144 | Widely patent fontanelles and sutures (HP:0004492) | 1.88506544 |
| 145 | Increased serum ferritin (HP:0003281) | 1.88256747 |
| 146 | Bulbar palsy (HP:0001283) | 1.87710945 |
| 147 | Attenuation of retinal blood vessels (HP:0007843) | 1.87055141 |
| 148 | Tetraparesis (HP:0002273) | 1.86909469 |
| 149 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.86247626 |
| 150 | Hyperacusis (HP:0010780) | 1.83120875 |
| 151 | Fetal akinesia sequence (HP:0001989) | 1.82681628 |
| 152 | Abnormal trabecular bone morphology (HP:0100671) | 1.82327932 |
| 153 | Prolonged bleeding time (HP:0003010) | 1.80520107 |
| 154 | Petechiae (HP:0000967) | 1.77683558 |
| 155 | Premature loss of primary teeth (HP:0006323) | 1.77351415 |
| 156 | Progressive visual loss (HP:0000529) | 1.77216530 |
| 157 | Purpura (HP:0000979) | 1.75909927 |
| 158 | Nephritis (HP:0000123) | 1.75156380 |
| 159 | Gastrointestinal inflammation (HP:0004386) | 1.72908708 |
| 160 | Inflammation of the large intestine (HP:0002037) | 1.72781942 |
| 161 | Hypophosphatemia (HP:0002148) | 1.72583503 |
| 162 | Supernumerary nipples (HP:0002558) | 1.72211792 |
| 163 | Dementia (HP:0000726) | 1.71943958 |
| 164 | Peripheral hypomyelination (HP:0007182) | 1.69972872 |
| 165 | Choanal stenosis (HP:0000452) | 1.69684721 |
| 166 | Cheilitis (HP:0100825) | 1.67487614 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.95496706 |
| 2 | MAPK15 | 3.60794779 |
| 3 | ERN1 | 3.48667927 |
| 4 | RIPK4 | 3.39751445 |
| 5 | KIT | 3.31821871 |
| 6 | PKN2 | 3.02164979 |
| 7 | TESK2 | 2.76945924 |
| 8 | SCYL2 | 2.57244633 |
| 9 | MAP4K1 | 2.47171464 |
| 10 | TBK1 | 2.43328895 |
| 11 | CAMK1D | 2.42236757 |
| 12 | PDK2 | 2.38544482 |
| 13 | BLK | 2.37955581 |
| 14 | TYK2 | 2.33493784 |
| 15 | PRPF4B | 2.23020976 |
| 16 | MAP3K3 | 2.06884614 |
| 17 | RIPK1 | 1.98042444 |
| 18 | CSF1R | 1.95115914 |
| 19 | CAMK1G | 1.86275224 |
| 20 | WNK4 | 1.72277813 |
| 21 | FES | 1.70989337 |
| 22 | TAOK2 | 1.63657604 |
| 23 | TGFBR2 | 1.61959680 |
| 24 | TTN | 1.59260161 |
| 25 | NME2 | 1.53472618 |
| 26 | CDK12 | 1.48945213 |
| 27 | SMG1 | 1.46538062 |
| 28 | SIK2 | 1.42611747 |
| 29 | FGR | 1.37654278 |
| 30 | SYK | 1.37310785 |
| 31 | ICK | 1.35856238 |
| 32 | CAMKK1 | 1.35567486 |
| 33 | IRAK3 | 1.35401546 |
| 34 | EEF2K | 1.35290563 |
| 35 | MAP3K10 | 1.34961651 |
| 36 | HCK | 1.32145943 |
| 37 | MAP3K9 | 1.30768557 |
| 38 | PTK6 | 1.30404748 |
| 39 | JAK1 | 1.30377471 |
| 40 | JAK3 | 1.28755385 |
| 41 | TAOK3 | 1.27155714 |
| 42 | IRAK2 | 1.25455172 |
| 43 | ZAP70 | 1.24775035 |
| 44 | MATK | 1.22086226 |
| 45 | BMX | 1.20867569 |
| 46 | EPHB1 | 1.20209093 |
| 47 | IRAK4 | 1.19687269 |
| 48 | CAMKK2 | 1.19128358 |
| 49 | JAK2 | 1.17424941 |
| 50 | DAPK2 | 1.17249234 |
| 51 | PAK4 | 1.16199948 |
| 52 | LRRK2 | 1.13859776 |
| 53 | PRKD2 | 1.10266693 |
| 54 | ARAF | 1.09040886 |
| 55 | MST1R | 1.08461394 |
| 56 | IKBKE | 1.07602520 |
| 57 | DDR2 | 1.05227438 |
| 58 | IKBKB | 1.05078247 |
| 59 | MAP2K3 | 1.03053541 |
| 60 | KSR2 | 1.03038344 |
| 61 | CSK | 1.02381034 |
| 62 | CDC42BPA | 1.02324128 |
| 63 | MAP3K13 | 1.01696586 |
| 64 | MAP3K11 | 1.01587167 |
| 65 | GRK6 | 0.98483081 |
| 66 | NEK2 | 0.94859258 |
| 67 | MAPK11 | 0.94157646 |
| 68 | ABL2 | 0.88973957 |
| 69 | MAPK12 | 0.88788663 |
| 70 | PDK1 | 0.88185426 |
| 71 | CDK15 | 0.87340670 |
| 72 | BTK | 0.87314445 |
| 73 | ALK | 0.86914017 |
| 74 | TYRO3 | 0.86577106 |
| 75 | LMTK2 | 0.85852506 |
| 76 | PDPK1 | 0.85813932 |
| 77 | CDK6 | 0.84234097 |
| 78 | STK10 | 0.81208748 |
| 79 | CDK11A | 0.81192920 |
| 80 | EGFR | 0.80152130 |
| 81 | CDK18 | 0.79547906 |
| 82 | LCK | 0.79304553 |
| 83 | MAP3K14 | 0.79080971 |
| 84 | ACVR1B | 0.78005306 |
| 85 | CDK4 | 0.77738214 |
| 86 | TESK1 | 0.76407960 |
| 87 | DAPK3 | 0.72455169 |
| 88 | MAP2K6 | 0.72064138 |
| 89 | PIM1 | 0.71241142 |
| 90 | LYN | 0.69412583 |
| 91 | PRKCH | 0.68639343 |
| 92 | MARK2 | 0.66643645 |
| 93 | PAK6 | 0.65552751 |
| 94 | CDK14 | 0.61336068 |
| 95 | MOS | 0.59864949 |
| 96 | RPS6KA2 | 0.59813561 |
| 97 | PIM2 | 0.59558313 |
| 98 | PRKD1 | 0.57615248 |
| 99 | PRKD3 | 0.57173112 |
| 100 | TLK1 | 0.55341975 |
| 101 | RET | 0.54918490 |
| 102 | DAPK1 | 0.54741021 |
| 103 | DYRK1B | 0.54562443 |
| 104 | ABL1 | 0.54010756 |
| 105 | STK4 | 0.53853933 |
| 106 | NEK9 | 0.52102466 |
| 107 | SIK1 | 0.51455062 |
| 108 | RPS6KA4 | 0.51086566 |
| 109 | MAPKAPK3 | 0.49984839 |
| 110 | MTOR | 0.49150867 |
| 111 | PDGFRA | 0.49107130 |
| 112 | RPS6KA6 | 0.48807217 |
| 113 | STK16 | 0.48551680 |
| 114 | FYN | 0.47122126 |
| 115 | GSK3A | 0.46182389 |
| 116 | PRKCD | 0.45836308 |
| 117 | AKT2 | 0.45756298 |
| 118 | RPS6KC1 | 0.45039978 |
| 119 | RPS6KL1 | 0.45039978 |
| 120 | PTK2B | 0.44906011 |
| 121 | SIK3 | 0.44752477 |
| 122 | FLT3 | 0.44340312 |
| 123 | RPS6KA1 | 0.43775917 |
| 124 | BRAF | 0.43665226 |
| 125 | MUSK | 0.43374204 |
| 126 | TAOK1 | 0.42646737 |
| 127 | PDGFRB | 0.42228016 |
| 128 | PAK2 | 0.41347809 |
| 129 | TRPM7 | 0.41296545 |
| 130 | NTRK1 | 0.40940998 |
| 131 | MAP3K1 | 0.39478065 |
| 132 | FGFR3 | 0.38760309 |
| 133 | GRK7 | 0.38688521 |
| 134 | SRC | 0.37779199 |
| 135 | MAP3K6 | 0.37072211 |
| 136 | MAP3K8 | 0.36401406 |
| 137 | CHUK | 0.35797932 |
| 138 | SGK3 | 0.35640351 |
| 139 | MARK3 | 0.34556609 |
| 140 | MAP3K2 | 0.34410139 |
| 141 | WEE1 | 0.34036212 |
| 142 | PAK1 | 0.32964952 |
| 143 | FGFR4 | 0.32638330 |
| 144 | HIPK2 | 0.30889570 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.32376244 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 4.15367695 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.87626962 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.58875730 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.43482600 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.38916831 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.36141086 |
| 8 | Tuberculosis_Homo sapiens_hsa05152 | 2.25563236 |
| 9 | Phagosome_Homo sapiens_hsa04145 | 2.07303921 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.05549156 |
| 11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.00483600 |
| 12 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.96403522 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.95344609 |
| 14 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.90995951 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.90772404 |
| 16 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.64502538 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.64085629 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.59090937 |
| 19 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.58645902 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.55637418 |
| 21 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.48537479 |
| 22 | Bladder cancer_Homo sapiens_hsa05219 | 1.44951572 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.44278516 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.40929773 |
| 25 | Apoptosis_Homo sapiens_hsa04210 | 1.38356232 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.34708473 |
| 27 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.31187940 |
| 28 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.29203956 |
| 29 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.27818747 |
| 30 | Legionellosis_Homo sapiens_hsa05134 | 1.27220177 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26314636 |
| 32 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.22877595 |
| 33 | Salmonella infection_Homo sapiens_hsa05132 | 1.22120924 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.19672079 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18115685 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.14246392 |
| 37 | Measles_Homo sapiens_hsa05162 | 1.13297990 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.11887902 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.09776560 |
| 40 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.04575130 |
| 41 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.03028350 |
| 42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.00410393 |
| 43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.99904480 |
| 44 | Endocytosis_Homo sapiens_hsa04144 | 0.98074862 |
| 45 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.95808544 |
| 46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.94498891 |
| 47 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92209521 |
| 48 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89866875 |
| 49 | Prion diseases_Homo sapiens_hsa05020 | 0.88953899 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.88333714 |
| 51 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.87373730 |
| 52 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.87077291 |
| 53 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.86583674 |
| 54 | Melanogenesis_Homo sapiens_hsa04916 | 0.86428768 |
| 55 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.85101644 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84103519 |
| 57 | Galactose metabolism_Homo sapiens_hsa00052 | 0.82639838 |
| 58 | Hepatitis B_Homo sapiens_hsa05161 | 0.81909412 |
| 59 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.80861482 |
| 60 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.79467749 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78618530 |
| 62 | Amoebiasis_Homo sapiens_hsa05146 | 0.77464483 |
| 63 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.77054174 |
| 64 | Glioma_Homo sapiens_hsa05214 | 0.75196803 |
| 65 | Platelet activation_Homo sapiens_hsa04611 | 0.74709340 |
| 66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74378761 |
| 67 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.73760913 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.73191965 |
| 69 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.73148895 |
| 70 | Hepatitis C_Homo sapiens_hsa05160 | 0.71419990 |
| 71 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.69737322 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.69679129 |
| 73 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69534223 |
| 74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.69213331 |
| 75 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68677045 |
| 76 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68409484 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66017437 |
| 78 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64992500 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.61797325 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61626513 |
| 81 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.61281617 |
| 82 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.58825186 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58716116 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56195624 |
| 85 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55410658 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54744790 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53286224 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52681624 |
| 89 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52070273 |
| 90 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.49827384 |
| 91 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.49692983 |
| 92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49452072 |
| 93 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.48973226 |
| 94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48951325 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47240701 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47150486 |
| 97 | Sulfur relay system_Homo sapiens_hsa04122 | 0.46831358 |
| 98 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.46632225 |
| 99 | Viral myocarditis_Homo sapiens_hsa05416 | 0.46298761 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.45602800 |
| 101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44976032 |
| 102 | Allograft rejection_Homo sapiens_hsa05330 | 0.42738984 |
| 103 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.40983480 |
| 104 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.40766968 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40551845 |
| 106 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.39775050 |
| 107 | ABC transporters_Homo sapiens_hsa02010 | 0.39750241 |
| 108 | Lysine degradation_Homo sapiens_hsa00310 | 0.39679695 |
| 109 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.39539652 |
| 110 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.39179376 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | 0.39082329 |
| 112 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38503109 |
| 113 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38331525 |
| 114 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.38237922 |
| 115 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37926257 |
| 116 | HTLV-I infection_Homo sapiens_hsa05166 | 0.35714371 |
| 117 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.35180298 |
| 118 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.34867099 |
| 119 | Colorectal cancer_Homo sapiens_hsa05210 | 0.34852453 |
| 120 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33407743 |
| 121 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.26634298 |
| 122 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.26624742 |
| 123 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.26169463 |
| 124 | Circadian rhythm_Homo sapiens_hsa04710 | 0.25987806 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.23864675 |

